Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases

This publication has 13 references indexed in Scilit:

• Granulocyte colony–stimulating factor–mobilized peripheral blood stem cells in β-thalassemia patients
  Experimental Hematology, 1999
• Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 × 5 μg/kg) compared to a single dose (1 × 10 μg/kg)
  Bone Marrow Transplantation, 1999
• Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation
  Bone Marrow Transplantation, 1998
• Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation
  Bone Marrow Transplantation, 1998
• The kinetics of G‐CSF mobilization of CD34+ cells in healthy people
  Transfusion Medicine, 1997
• STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACY
  British Journal of Haematology, 1996
• THE PLACE OF BLOOD STEM CELLS IN ALLOGENEIC TRANSPLANTATION
  British Journal of Haematology, 1996
• Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
  The Lancet, 1996
• Optimization of Peripheral Blood Stem Cell Mobilization
  The International Journal of Cell Cloning, 1996
• G‐CSF‐mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft
  British Journal of Haematology, 1994